460 related articles for article (PubMed ID: 17902730)
1. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
[TBL] [Abstract][Full Text] [Related]
2. Investigator-blinded, controlled, and randomized comparative study on 1565 nm non-ablative fractional laser versus 5% minoxidil for treatment of androgenetic alopecia.
Qu H; Zhang R; Xin W; Jing H; Wang G; Gao L
J Cosmet Dermatol; 2024 May; 23(5):1638-1644. PubMed ID: 38247260
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial.
Rossi A; Caro G
J Cosmet Dermatol; 2024 Feb; 23(2):502-509. PubMed ID: 37798906
[TBL] [Abstract][Full Text] [Related]
4. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
Penha MA; Miot HA; Kasprzak M; Müller Ramos P
JAMA Dermatol; 2024 Apr; ():. PubMed ID: 38598226
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial.
Asilian A; Farmani A; Saber M
J Cosmet Dermatol; 2024 Mar; 23(3):949-957. PubMed ID: 38031516
[TBL] [Abstract][Full Text] [Related]
6. Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial.
Legiawati L; Suseno LS; Sitohang IBS; Yusharyahya SN; Pawitan JA; Liem IK; Kurniawati T; Ardelia A; Paramastri K
Stem Cell Res Ther; 2023 Aug; 14(1):210. PubMed ID: 37605227
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial.
Sadeghzadeh Bazargan A; Tavana Z; Dehghani A; Jafarzadeh A; Tabavar A; Alavi Rad E; Goodarzi A
J Cosmet Dermatol; 2024 Feb; 23(2):543-551. PubMed ID: 37650533
[TBL] [Abstract][Full Text] [Related]
8. Topical cetirizine for treating androgenetic alopecia: A systematic review.
Chen X; Xiang H; Yang M
J Cosmet Dermatol; 2022 Nov; 21(11):5519-5526. PubMed ID: 35976065
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis.
Abdi P; Awad C; Anthony MR; Farkouh C; Kenny B; Maibach HI; Ogunyemi B
Arch Dermatol Res; 2023 Dec; 315(10):2775-2785. PubMed ID: 37665358
[TBL] [Abstract][Full Text] [Related]
10. Comparative Clinical Study Evaluating the Efficacy and Safety of Topical 5% Cetosomal Minoxidil and Topical 5% Alcohol-Based Minoxidil Solutions for the Treatment of Androgenetic Alopecia in Indian Men.
Sattur S; Talathi A; Shetty G; Arsiwala S; Pereira R; Dhoot D
Cureus; 2023 Oct; 15(10):e46568. PubMed ID: 37937040
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of 2% minoxidil alone against combination of 2% minoxidil and low-level laser therapy in female pattern hair loss-A randomized controlled trial in Chinese females.
Yang X; Qiao R; Cheng W; Lan X; Li Y; Jiang Y
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103966. PubMed ID: 38211777
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of 5% topical minoxidil versus 5 mg oral biotin versus topical minoxidil and oral biotin on hair growth in men: randomized, crossover, clinical trial.
Valentim FO; Miola AC; Miot HA; Schmitt JV
An Bras Dermatol; 2024; 99(4):581-584. PubMed ID: 38688776
[No Abstract] [Full Text] [Related]
13. Efficacy of Low-Level Laser Therapy in Androgenetic Alopecia - A Randomized Controlled Trial.
Sondagar DM; Mehta HH; Agharia RS; Jhavar MK
Int J Trichology; 2023; 15(1):25-32. PubMed ID: 37305186
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of the ablative fractional 2940-nm Er: YAG laser for the treatment of androgenetic alopecia.
Dai R; Yang X; Su Y; Wu X
Lasers Med Sci; 2024 May; 39(1):128. PubMed ID: 38724798
[TBL] [Abstract][Full Text] [Related]
15. Comparing Single-spin Versus Double-spin Platelet-rich Plasma (PRP) Centrifugation Methods on Thrombocyte Count and Clinical Improvement of Androgenetic Alopecia: A Preliminary, Randomized, Double-blind Clinical Trial.
Legiawati L; Yusharyahya SN; Bernadette I; Novianto E; Priyanto MH; Gliselda KC; Iriyanty S; Mutiara R
J Clin Aesthet Dermatol; 2023 Dec; 16(12):39-44. PubMed ID: 38125672
[TBL] [Abstract][Full Text] [Related]
16. Effect of platelet counts and activator in platelet-rich plasma on the treatment of androgenetic alopecia, split-head comparison: A randomised, double-blind study.
Singh SK; Singh S
Indian J Dermatol Venereol Leprol; 2023; 89(5):647-655. PubMed ID: 37067143
[TBL] [Abstract][Full Text] [Related]
17. Observing the clinical efficacy of combined serum microneedle therapy for moderate to severe androgenetic alopecia in scalp repair.
Zhang F; Jia S; Ye B; Li F; Zhang J; Jin Q; Li M
Skin Res Technol; 2024 Feb; 30(2):e13612. PubMed ID: 38348763
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Platelet-Rich Plasma versus 5% Topical Monixidil for the Treatment of Androgenetic Alopecia.
Afzal G; Ahmed N; Zahoor F; Malik T; Farooq O
J Coll Physicians Surg Pak; 2024 Jan; 34(1):11-15. PubMed ID: 38185953
[TBL] [Abstract][Full Text] [Related]
19. Promotive effect of topical ketoconazole, minoxidil, and minoxidil with tretinoin on hair growth in male mice.
Aldhalimi MA; Hadi NR; Ghafil FA
ISRN Pharmacol; 2014; 2014():575423. PubMed ID: 24734193
[TBL] [Abstract][Full Text] [Related]
20. Split-scalp pilot study to evaluate effectiveness of Minoxidil 0,5% MMP® versus Topical Minoxidil 5% in the treatment of Female Pattern Hair Loss.
Corrêa AC; Machado CJ; Carneiro SCS
Arch Dermatol Res; 2024 Jun; 316(6):313. PubMed ID: 38822940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
